InstantLabs Secures Controlling Investment From Angeon Group

Angeon
BALTIMORE, Feb. 23, 2017 /PRNewswire/ — InstantLabs Medical Diagnostics Corporation, Inc. (InstantLabs) announced today that it has entered into an agreement for a controlling investment from Angeon Group, LLC (Angeon), an independent, private investment company focused on supporting growth-oriented businesses
Find Out More

Thoughts on SENA2015, Oceana’s Blue Crab Report, and the State of the Seafood Industry

As our portfolio of InstantID™ Seafood Identification test kits continues to grow, offering more tools to the industry, it seems the selected target species of the first test we developed in the InstantID™ seafood line is undeniably relevant. Highlighting the relevance is Oceana’s just-released report outlining the egregious extent of seafood fraud present in the Blue Crab industry. This report is a companion to the groundbreaking 2013 report titled “Oceana Reveals Seafood Fraud Nationwide”, detailing the amount of seafood fraud concerning numerous seafood selections in the nation’s grocery stores and restaurants.
Find Out More